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1. Introduction 
The two heat-stable trypsin-labile proteins which 
inhibit the low molecular weight phosphorylase phos- 
phatase [l-4] have been isolated from rabbit skeletal 
muscle. The activity of one of the inhibitors, termed 
inhibitor 1 (I,), is controlled by phosphorylation 
catalyzed by cAMPdependent protein kinase and 
dephosphorylation catalyzed by a MnF-dependent 
phosphatase [2,5,6]. The phosphorylated form of I1 
is inhibitory whereas the dephosphorylated form is 
not active [2,6]. 
In view of high concentration of I1 in skeletal 
muscle, its high potency as an inhibitor, and control 
of its activity by phosphorylation, it has been sug- 
gested that It may play an important role in the 
regulation of phosphoprotein phosphatase [2,6,7]. 
Normal rabbits injected with epinephrine have 
increased levels of phosphorylated form of I1 [7]. 
However, insulin increases the rate of activation of 
glycogen synthase in tissues of control and diabetic 
animals [&-IO] and may act by inhibiting the CAMP- 
dependent protein kinase [ 1 l] or by activating a
phosphoprotein phosphatase. Both of these changes 
may result in a decrease in the phosphorylation state 
of 11. 
Here we have studied the effects of epinephrine 
and insulin on the phosphorylation state of I1. The 
hindlimb perfusion technique was used to investigate 
the effects of these hormones in a controlled situa- 
tion in intact rat muscle. 
2. Materials and methods 
2.1. Preparation of enzymes and 32P substrates 
High molecular weight phosphoprotein phosphatase 
Elsevier/North-Holland Biomedical Press 
was prepared as in [ 121. Low molecular weight phos- 
phoprotein phosphatase was prepared from the super- 
natant of amylase-treated glycogen-protein complex 
of rabbit muscle [13]. The supernatant was concen- 
trated by ammonium sulfate, treated with 70% 
ethanol and the phosphatase purified by DEAE- 
cellulose chromatography as in [ 141. Skeletal muscle 
phosphorylase kinase, phosphorylase b and the 
catalytic subunit of CAMP-dependent protein kinase 
were prepared by the methods in [15], [16] and [17], 
respectively. [Y-~~P]ATP and 32P phosphorylase a 
were prepared as in [18] and [ 193, respectively. 
2.2. Hindlim b perfision 
Hindlimbs were perfused following [20] as modi- 
fied [21 J. Epinephrine (10d9, lo-*, IO-‘M) with or 
without insulin (1 mu/ml), with or without pro- 
pranolol(l0” M) was infused for 30 mm in the pres- 
ence of 10 mM glucose. At the end of the perfusion 
period, muscle tissue was quick frozen in liquid nitro- 
gen for determination later of phosphorylation state 
of Ii. 
2.3. Preparation of samples and assays 
Phosphorylase phosphatase I1 was extracted from 
skeletal muscle as in [7]. The activity of I1 was deter- 
mined by its ability to inhibit the purified low molec- 
ular weight phosphatase. Phosphorylase phosphatase 
assay conditions and definition of unit activity were 
as in [22] except hat 3.75 mM EDTA was included 
in the assay. One unit of inhibitor activity is defined 
as the amount of inhibitor which inhibits 7.5 mU 
phosphatase activity by 50%. All enzyme or inhibitor 
dilutions were made in 50 mM Tri-HCl (pH 7.5) 
containing 10% sucrose, 1 mM EDTA, 1 mg/ml BSA 
and 30 mM 2-mercaptoethanol. 
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2.4. Phosphorylation and dephosphorylation of 
inhibitor II 
Phosphorylation of the Ir was carried out in a 
mixture containing 50 mM Tris buffer (pH 7.5), 30 
mM 2-mercaptoeth~ol, 10 mM magnesium acetate, 
0.5 mM ATP, 20 ~1 i~ibitor sample and 2500 units 
of catalytic subunit of CAMP-dependent protein kinase 
in 0.1 ml total vol. The dephosphorylation f inhibitor 
was carried out in 100 1.t1 mixture containing 50 mM 
Tris buffer (pH 7.5) 30 mM 2-mercaptoethanol, 
1 mM M&l,, 50 ~1 of sample and 2.5 units of purified 
high molecular weight phosphoprotein phosphatase. 
Both phosphorylation and dephospho~lation were at 
30°C for 90 min and terminated by boiling. Appro- 
priate dilutions were then made to assay the activity 
of the inhibitor. Preliminary experiments showed that 
the amount of protein kinase or phosphatase utilized 
were far in excess of that required for maximal phos- 
phorylation or dephospho~lation, respectively, of
the I,. 
3. Results and discussion 
The basic strategy for determining the degree of 
phospho~lation of I1 in perfused rat muscle was that 
in 171 for rabbit skeletal muscle. The homogenization 
of frozen muscle powder in 2% trichloroacetic acid- 
solubilized Ii, but little or none of inhibitor 2 (I& 
The degree of phosphorylation of I, in extracts was 
determined by assaying the extracts for Ii activity 
prior to and after phosphorylation and dephos- 
phorylation of extracts (section 2). Dephosphoryla- 
tion of the extracts by high molecular weight phos- 
phatase l d to complete loss in inhibitor activity thus 
establishing the absence of any IZ. This loss of activity 
could however be reversed by phosphorylation by 
CAMP-dependent protein kinase. Units of Ii activity 
prior to phosphorylation divided by units of activity 
obtained after maximal phosphorylation gave the 
ratio of I1 in the phospho~lated state. When puri- 
fied I, was added to the phosphatase r action mixture 
in increasing concentration, the inhibition was linear 
up to 50-60% loss of phosphatase activity. Therefore 
the amount of inhibitor sample added to the phos- 
phatase assay mixture was such that inhibition was 
<20-40%. 
Fig.1 shows the effect of perfusing rat skeletal 
muscle with epinephrine on the phospho~lation 
state of It. In the absence of epinephrine, only 
254 
S-10% of the inhibitor was phosphorylated suggesting 
little inhibition of phosphatase by Ii in the absence 
of hormones. The phosphorylation state of Ii 
increased 2-3-fold over this basal evel at the lowest 
dose of epinephrine tested (10V9 M) and reached 
50-60% at 10e7 M epinephrine. This implies that the 
phosphorylation and hence the inhibitory activity of 
Ii is very sensitive to epinephrine. As shown in fig.1 
propranolol markedly inhibited the phosphorylation 
of I1 by 10m7 M epinephrine, thus suggesting that the 
stimulation of phosphorylation of I, by epinephrine 
in skeletal muscle is through the classical 8-adrenergic 
mechanism, This is also in agreement with [23] which 
shows that in skeletal muscle activation of phospho- 
rylase by epinephrine occurs through the B-adrenergic 
mechanism only. Perfusion with 1 mU insulin/ml in 
the presence or absence of epinephrine did not affect 
the phosphorylation state of Ir. 
Although the physiolo~c~ function of phosphatase 
inhibitors is not well understood, several properties of 
Ii suggest that it may be involved in the regulation of 
10‘8 
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Fig.1. The effect of saline or epinephrine (open bars), 
epinephrine plus insulin (hatched bars) and epinephrine plus 
propranolol (crossed bars) on the phosphorylation state of 
phosphorylase phosphatase 1, in rat skeletal muscle. The 
hindlimbs were perfused for 30 min with the hormones in 
the presence of 10 mM Dgiucose and muscle tissue was 
freeze clamped at the end of the study. Values are expressed 
as mean f SEM and the no. perfusions are listed within each 
bar. 
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glycogen metabolism. The concentration of I1 in 
skeletal muscle (1.4 PM, [6]) is comparable to the 
concentration of a general phosphoprotein phospha- 
tase which has been shown to dephosphorylate glyco- 
gen synthase, phosphorylase a and phosphorylase 
kinase [ 3,4]. The I 1 has a relatively low Ki of -2 nM 
[4] suggesting that it could inhibit a large proportion 
of phosphatase in muscle. The control of I1 activity 
by covalent modification catalyzed by CAMP- 
dependent protein kinase [2,5,6] suggests hat its 
activity could be turned on and off rapidly by p-ago- 
nists such as epinephrine. In spite of these consider- 
ations which suggest a role of I, in glycogen metab- 
olism in skeletal muscle, there is evidence [24] that 
phosphorylase phosphatase activity in freshly prepared 
skeletal muscle extracts is not inhibited by 11. No 
data were given, however, on the possible ffect of 
endogenous phosphatases and proteases on the added 
I~. In contrast, I, inhibits phosphorylase phosphatase 
activity by 50-70% in tissue extracts of brain, liver, 
heart, mammary gland and skeletal muscle [25]. 
the phosphorylation and hence the inhibitory activity 
of Ir. An increase in CAMP levels in response to 
increased epinephrine l vels would increase phos- 
phorylase kinase activity and lower phosphoprotein 
phosphatase activity thus allowing activation of phos- 
phorylase . 
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Fig.2. Proposed scheme for the mechanism of inhibition of phosphorylase phosphatase activity by CAMP in rat skeletal muscle. 
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